YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
BALTIMORE, Oct. 8, 2026 /PRNewswire/ -- 1919 Investment Counsel, LLC ("1919"), a subsidiary of Stifel Financial Corp. ("Stifel"), is proud to announce its recognition on CNBC's prestigious Financial Advisor 100 list for 2026.1919 Investmen…
The 10-year yield eased from a 24-year high Wednesday after the US Treasury Department auctioned $39 PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Investing.com -- Stifel has identified leading opportunities in the Analog and Edge AI semiconductor space, highlighting companies with differentiated solutions in the high-end analog market and those positioned to benefit from the growing…
SAN DIEGO, October 07, 2026--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (the "Company") (NYSE: IIPR) announced today that it has commenced a public offering of its Series B Cumulative Redeemable Preferred Stock ("Series B Pref…
BALTIMORE, Sept. 30, 2026 /PRNewswire/ -- 1919 Investment Counsel, LLC ("1919"), a subsidiary of Stifel Financial Corp. ("Stifel"), is proud to announce its inclusion in Barron's 2026 Top 100 RIA Firms list. Ranked No. 33 nationally, 1919…
This article first appeared on GuruFocus. Microsoft (NASDAQ:MSFT) received a rating upgrade from Stifel, with analyst Brad Reback moving the stock to Buy from Hold and lifting the price target to $575 from $530. The firm sees room for Micr…
Investing.com -- Stifel has highlighted its top stock selection in the real estate investment trust sector, featuring First Industrial Realty Trust as the firm's current favorite idea from its equity research analysts. Still guessing which…
Stifel Financial Corporation ST. LOUIS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for August 31, 2026, to provide timely information to investors on certain key performan…
Mineralys Therapeutics, Inc. RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse ou…
Interest rates are rising again, inflation is still sticky, and suddenly the sleepy corner of brokerage cash and margin lending looks anything but boring. When the Fed pushes the benchmark rate to a range of 3.75% to 4%, every idle dollar…
Microsoft stock momentum is expected to continue as OpenAI revenue contribution to Microsoft accelerates. Continue Reading
CAMBRIDGE, Mass., September 23, 2026--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that management will present at the Stifel 2026 Virtual Cardiometabolic Forum. The fireside chat…
Altimmune, Inc GAITHERSBURG, Md., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management w…
Lexeo Therapeutics NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high unmet need, today announced that the Company will…
Micron (NASDAQ: MU) stock jumped nearly 5% in early trading Monday, before retreating to about a 1.8% gain as of 10:10 a.m. ET. You can thank investment banker Stifel for that. Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors…
BRP now carries a higher Fair Value Estimate of CA$103.07, up from CA$97.22, which lines up more closely with the Street price targets that have been cited after the latest update. Recent analyst commentary reflects this shift, with more u…
Plains GP Holdings is under fresh scrutiny as fair value in one key model shifts from about US$24.93 to about US$25.77, a move that brings price targets into slightly higher territory. Recent analyst research connects this change to the Si…
Stifel Financial (SF) just moved to deepen its venture banking bench by bringing in three senior leaders with long Silicon Valley Bank and venture ecosystem experience across Boston, New York City, and the broader East Coast. Recent appoin…
SAN DIEGO, September 17, 2026--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on Thursday, September 24, 2026, at…
Stifel Financial Corporation Industry Veterans Appointed in New York and Boston, Augmenting Venture Banking and Venture Capital Coverage Nationwide ST. LOUIS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today annou…
Artiva Biotherapeutics, Inc. SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapi…
Recludix Pharma, Inc. SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy W…
1 Profitable Stock with Exciting Potential and 2 We Avoid Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive…
STOCKHOLM, SE / ACCESS Newswire / September 17, 2026 / Vicore Pharma Holding AB (publ) (STO:VICO)(NASDAQ:VCRE), a clinical-stage biopharmaceutical company unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor ag…
Braveheart Bio, Inc. SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other…
Odyssey Therapeutics Inc BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) ("Odyssey" or the "Company"), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients s…
Energy Transfer LP (NYSE:ET) has surged by almost 30% since the beginning of 2026, propelled by its strong performance, high natural gas demand in the US, and new pipeline opportunities from data centers. The stock has also now received a…
Keefe, Bruyette & Woods, Inc. (KBW) NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Fin…
Stifel CEO Ron Kruszewski joins Inside the ICE House to mark 30 years leading the 136-year-old firm and reflect on navigating constant change. He explains why he sees AI as a powerful accelerator rather than a replacement for human judgmen…
Stifel Financial Corporation Industry veterans Conor Daly and Jim Franz appointed Co-Heads of European Leveraged Finance Sales ST. LOUIS & LONDON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the app…
Spotting Winners: Moelis (NYSE:MC) And Investment Banking & Brokerage Stocks In Q2 The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take…
A Look Back at Investment Banking & Brokerage Stocks' Q2 Earnings: Stifel (NYSE:SF) Vs The Rest Of The Pack Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Sti…
Watch Highlights From the 2025 Palm Beach CorpGov Forum: CorpGov, IPO Edge and PE Edge will host the sixth annual Palm Beach CorpGov Forum on November 4-5, 2026, at the Palm Beach Lake Pavilion and The Cove Club, both located waterfront wi…
Microsoft France headquarters by JeanLuclchard via Shutterstock Microsoft (MSFT) stock just got another vote of confidence from Wall Street. Stifel raised its price target on Microsoft to $530 from $450 while keeping a "Hold" rating. The f…
1 Mid-Cap Stock for Long-Term Investors and 2 We Brush Off Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corpo…
As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the investment banking & brokerage industry, including Piper Sandler (NYSE:PIPR) and its peers. Investment banks and brokerages facilitate capital…